1c:{"metadata":[["$","title","0",{"children":"NIH VideoCast - Toward the Use of Buprenorphine in Infants (Day 2)"}],["$","meta","1",{"name":"description","content":"HEAL/ACT NOW Buprenorphine Workshop expands the knowledge base in medical and associated sciences regarding the treatment of neonatal opioid withdrawal syndrome in order to enhance the Nation's economic well-being and public health across generations. The proposed workshop will discuss current and future practical considerationsregarding the use of buprenorphine in infants for the treatment of neonatal opioid withdrawal syndrome (NOWS) and other pediatric conditions requiring opioid therapy. To conduct a workshop to discuss the nuances and practical issues thatneed to be considered regarding the use of buprenorphine in infants.

For more information go to https://heal.nih.gov/events/2020-buprenorphine-infants"}],["$","meta","2",{"name":"publisher","content":"National Institutes of Health"}],["$","meta","3",{"property":"og:title","content":"NIH VideoCast - Toward the Use of Buprenorphine in Infants (Day 2)"}],["$","meta","4",{"property":"og:description","content":"HEAL/ACT NOW Buprenorphine Workshop expands the knowledge base in medical and associated sciences regarding the treatment of neonatal opioid withdrawal syndrome in order to enhance the Nation's economic well-being and public health across generations. The proposed workshop will discuss current and future practical considerationsregarding the use of buprenorphine in infants for the treatment of neonatal opioid withdrawal syndrome (NOWS) and other pediatric conditions requiring opioid therapy. To conduct a workshop to discuss the nuances and practical issues thatneed to be considered regarding the use of buprenorphine in infants.

For more information go to https://heal.nih.gov/events/2020-buprenorphine-infants"}],["$","meta","5",{"property":"og:url","content":"https://uat.d1rkikwu4q8tg.amplifyapp.com/watch/bd6552ae-d5db-11f0-9cf9-12c45c580ad9"}],["$","meta","6",{"property":"og:site_name","content":"NIH VideoCast"}],["$","meta","7",{"property":"og:image","content":"https://nihcit.rev.vbrick.com/api/v2/media/videos/thumbnails/331ba554-c96b-47d7-bcc1-32f85d7599e0.jpg"}],["$","meta","8",{"property":"og:type","content":"website"}],["$","meta","9",{"name":"twitter:card","content":"summary_large_image"}],["$","meta","10",{"name":"twitter:title","content":"NIH VideoCast - Toward the Use of Buprenorphine in Infants (Day 2)"}],["$","meta","11",{"name":"twitter:description","content":"HEAL/ACT NOW Buprenorphine Workshop expands the knowledge base in medical and associated sciences regarding the treatment of neonatal opioid withdrawal syndrome in order to enhance the Nation's economic well-being and public health across generations. The proposed workshop will discuss current and future practical considerationsregarding the use of buprenorphine in infants for the treatment of neonatal opioid withdrawal syndrome (NOWS) and other pediatric conditions requiring opioid therapy. To conduct a workshop to discuss the nuances and practical issues thatneed to be considered regarding the use of buprenorphine in infants.

For more information go to https://heal.nih.gov/events/2020-buprenorphine-infants"}],"$L22","$L23","$L24"],"error":null,"digest":"$undefined"}